Layoffs
Vical announced its restructuring late Tuesday.
Sanofi has announced major restructuring, which will involve about 400 job cuts in the U.S.
Novelion will slash an unknown number of jobs as it initiates “significant cost reduction plans.”
The layoff leaves 58 percent of FDA employees on the job, which Gottlieb said is higher than the previous shutdown in 2013.
Sanofi has announced major restructuring, which will involve layoffs.
The cuts are being made as the company grapples with a debt of between $30 and $35B and a restructuring of its R&D in order to combat dramatically declining revenue from its generic pipeline.
This Latest move is a wide-ranging effort to boost competitiveness.
Almost one year after filing a NDA for an ADHD drug and less than one year after announcing it secured $200M in financing, Ironshore Pharma has closed its doors.
Changes are coming to Medtronic.
GlaxoSmithKline CEO Emma Walmsley is not done reshaping her leadership team as she continues to overhaul the company’s pharmaceutical division.
PRESS RELEASES
